东阳光长江药业(01558.HK) 公布截至去年12月底止全年业绩,营业额37.24亿元人民币(下同),按年跌40.8%。纯利4.83亿元,按年跌75.8%;每股盈利0.55元。不派息。(ad/u)(港股报价延迟最少十五分钟。沽空资料截至 2025-03-28 16:25。)
公布日期 | 派息事项 | 派息内容 |
---|---|---|
2024/08/30 | 中期业绩 | 无派息 |
2024/05/16 | 特别中期业绩 | 特别股息:港元 1.5000 |
2024/03/28 | 末期业绩 | 无派息 |
2023/08/31 | 中期业绩 | 无派息 |
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.